IL37 and psoriasis: Additionally, Vandeghinste et al. (2018) used an anti-IL-17C reference antibody (MOR106) to inhibit the interaction of IL-17C with its receptor in both an IL-23-induced psoriasis mouse model and an MC903-induced AD mouse model.